UK’s Only Cholangiocarcinoma Charity Awards Over £350,000 to Leading Institutions in 2018 Grant funding Round

STANSTED, ESSEX, UNITED KINGDOM, June 26, 2018 /EINPresswire.com/ -- AMMF, the only charity in the UK dedicated to one of the world’s rarest and second most common primary liver cancer, cholangiocarcinoma (bile duct cancer), today announces that it has awarded over £350,000 in research grants so far in 2018 to leading national and international institutions to accelerate the path to finding a cure for this devastating and little-known cancer. Since its inception in 2002, AMMF has awarded over £1m (one million pounds sterling) in grants to support cholangiocarcinoma research at many of the UK’s leading research institutions, and internationally.

Commenting on the 2018 research grants, AMMF CEO Helen Morement explains, “AMMF is very pleased to be funding these new studies at top universities and hospitals, both in Europe and internationally. AMMF is passionate about supporting talented and dedicated research teams to take vital steps towards greater understanding of this little-known and poorly understood cancer, the incidence of which has risen steeply and steadily across the world over the past few decades. In 2013 it was the cause of 2,161 deaths in England alone.

"Although most cases occur in people over 60 years of age, this disease appears to be increasing across all age groups including younger people. The key to all future breakthroughs is early-stage research, which has the potential to provide both new insights into early and correct diagnosis, as well as into the development of new drugs and treatments."

To date, AMMF has funded or is currently funding research at:

• Imperial College London
• University College London
• The Institute of Hepatology London
• University of Birmingham
• University of Cambridge
• University of Edinburgh
• University of Nottingham
• University of East Anglia
• University of Manchester
• University of Liverpool
• Universities of Madrid and Pamplona
• University of Oxford
• Johns Hopkins University, USA

Ends

About AMMF

AMMF was founded and registered as a charity with the Charity Commission in 2002 (registered charity no 1091915). AMMF is the UK’s only cholangiocarcinoma charity, dedicated to tackling this devastating cancer on all fronts: providing information and support, campaigning to raise awareness, and encouraging and supporting research. In recent years an enormous and extremely worrying worldwide increase in cholangiocarcinoma’s incidence has been noted. Latest figures show there were 2,161 deaths caused by cholangiocarcinoma in 2013 in England alone (NCIN/Cancer52 report). The incidence appears to be increasing across all age groups, including younger people, and the cause of this ongoing increase is unknown. Much more research is desperately needed.

AMMF is dedicated to bringing about improvement for the cholangiocarcinoma patient, working closely throughout the UK with patients, families, carers, clinicians, healthcare professionals, researchers, politicians and policy makers, and collaborating internationally. For more information visit: www.ammf.org.uk (registered charity no.1091915).

Esther Porta
AMMF
+44 (0)1279 661 479
email us here